DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Pollmann H, Externest D, Ganser A , et al.
Efficacy, safety and tolerability of recombinant factor VIII (REFACTO) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria.
Haemophilia 2007;
13 (2) 131-143
We do not assume any responsibility for the contents of the web pages of other providers.